SEARCH

SEARCH BY CITATION

References

  • Bhangoo S., Ren D., Miller R. J. et al. (2007a) Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol. Pain 3, 38.
  • Bhangoo S. K., Ren D., Miller R. J., Chan D. M., Ripsch M. S., Weiss C., McGinnis C. and White F. A. (2007b) CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav. Immun. 21, 581591.
  • Bordet T. and Pruss R. M. (2009) Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain. Neurotherapeutics 6, 648662.
  • Bowersox S. S., Singh T., Nadasdi L., Zukowska-Grojec Z., Valentino K. and Hoffman B. B. (1992) Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action. J. Cardiovasc. Pharmacol. 20, 756764.
  • Brittain J. M., Chen L., Wilson S. M. et al. (2011a) Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2). J. Biol. Chem. 286, 3777837792.
  • Brittain J. M., Duarte D. B., Wilson S. M. et al. (2011b) Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca(2)(+) channel complex. Nat. Med. 17, 822829.
  • Brittain J. M., Pan R., You H., Brustovetsky T., Brustovetsky N., Zamponi G. W., Lee W. H. and Khanna R. (2012) Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. Channels (Austin) 6, 5259.
  • Caterina M. J. and Julius D. (2001) The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 24, 487517.
  • Doggrell S. A. (2004) Intrathecal ziconotide for refractory pain. Expert Opin. Investig. Drugs 13, 875877.
  • Duchardt F., Fotin-Mleczek M., Schwarz H., Fischer R. and Brock R. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8, 848866.
  • Eroglu C., Allen N. J., Susman M. W. et al. (2009) Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139, 380392.
  • Fuchs S. M. and Raines R. T. (2004) Pathway for polyarginine entry into mammalian cells. Biochemistry 43, 24382444.
  • Fukata Y., Itoh T. J., Kimura T. et al. (2002) CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 4, 583591.
  • Gee N. S., Brown J. P., Dissanayake V. U., Offord J., Thurlow R. and Woodruff G. N. (1996) The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J. Biol. Chem. 271, 57685776.
  • Goldberg D. S. and McGee S. J. (2011) Pain as a global public health priority. BMC Public Health 11, 770.
  • Greffrath W., Kirschstein T., Nawrath H. and Treede R. (2001) Changes in cytosolic calcium in response to noxious heat and their relationship to vanilloid receptors in rat dorsal root ganglion neurons. Neuroscience 104, 539550.
  • Harstall C. (2003) How prevalent is chronic pain? Pain Clin. Updates vol XI, 14.
  • Himmel H. M., Kiss T., Borvendeg S. J., Gillen C. and Illes P. (2002) The arginine-rich hexapeptide R4W2 is a stereoselective antagonist at the vanilloid receptor 1: a Ca2+ imaging study in adult rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther. 301, 981986.
  • Joseph E. K., Chen X., Khasar S. G. and Levine J. D. (2004) Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain 107, 147158.
  • Malmberg A. B. and Yaksh T. L. (1994) Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J. Neurosci. 14, 48824890.
  • Maneuf Y. P., Luo Z. D. and Lee K. (2006) alpha2delta and the mechanism of action of gabapentin in the treatment of pain. Semin. Cell Dev. Biol. 17, 565570.
  • Mitchell D. J., Kim D. T., Steinman L., Fathman C. G. and Rothbard J. B. (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56, 318325.
  • Piekarz A. D., Due M. R., Khanna M. et al. (2012) CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy. Mol. Pain 8, 54.
  • Planells-Cases R., Aracil A., Merino J. M., Gallar J., Perez-Paya E., Belmonte C., Gonzalez-Ros J. M. and Ferrer-Montiel A. V. (2000) Arginine-rich peptides are blockers of VR-1 channels with analgesic activity. FEBS Lett. 481, 131136.
  • Ripsch M. S., Ballard C. J., Khanna M., Hurley J. H., White F. A. and Khanna R. (2012) A peptide uncoupling CRMP-2 from the presynaptic Ca2 +  channel complex demonstrate efficacy in animal models of migraine and AIDS therapy-induced neuropathy. Transl. Neurosci. 3, 18.
  • Saegusa H., Kurihara T., Zong S., Kazuno A., Matsuda Y., Nonaka T., Han W., Toriyama H. and Tanabe T. (2001) Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2 +  channel. EMBO J. 20, 23492356.
  • Sarko D., Beijer B., Garcia B. R., Nothelfer E. M., Leotta K., Eisenhut M., Altmann A., Haberkorn U. and Mier W. (2010) The pharmacokinetics of cell-penetrating peptides. Mol. Pharm. 7, 22242231.
  • Schmidtko A., Lotsch J., Freynhagen R. and Geisslinger G. (2010) Ziconotide for treatment of severe chronic pain. Lancet 375, 15691577.
  • Suter M. R., Berta T., Gao Y. J., Decosterd I. and Ji R. R. (2009) Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury. Mol. Pain 5(53), 53.
  • Tunnemann G., Ter-Avetisyan G., Martin R. M., Stockl M., Herrmann A. and Cardoso M. C. (2008) Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. J. Pept. Sci. 14, 469476.
  • Wang Y., Wilson S. M., Brittain J. M., Ripsch M. S., Salome C., Park K. D., White F. A., Khanna R. and Kohn H. (2011) Merging structural motifs of functionalized amino acids and alpha-aminoamides results in novel anticonvulsant compounds with significant effects on slow and fast inactivation of voltage-gated sodium channels and in the treatment of neuropathic pain. ACS Chem. Neurosci. 2, 317322.
  • Wender P. A., Mitchell D. J., Pattabiraman K., Pelkey E. T., Steinman L. and Rothbard J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl Acad. Sci. USA 97, 1300313008.
  • Wheeler D. G., Groth R. D., Ma H., Barrett C. F., Owen S. F., Safa P. and Tsien R. W. (2012) Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+) signaling to control CREB-dependent gene expression. Cell 149, 11121124.
  • Wilson S. M., Brittain J. M., Piekarz A. D. et al. (2011) Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex. Channels (Austin) 5, 449456.
  • Wilson S. M., Schmutzler B. S., Brittain J. M. et al. (2012a) Inhibition of transmitter release and attenuation of AIDS therapy-induced and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides. J. Biol. Chem. 287, 3506535077.
  • Wilson S. M., Xiong W., Wang Y. et al. (2012b) Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization. Neuroscience 210, 451466.
  • Winter J., Dray A., Wood J. N., Yeats J. C. and Bevan S. (1990) Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin. Brain Res. 520, 131140.
  • Zhang Y., Wang Y. H., Zhang X. H., Ge H. Y., Arendt-Nielsen L., Shao J. M. and Yue S. W. (2008) Proteomic analysis of differential proteins related to the neuropathic pain and neuroprotection in the dorsal root ganglion following its chronic compression in rats. Exp. Brain Res. 189, 199209.